Kopetz, S.
The University of Texas MD Anderson Cancer Center
2 papers on CoChatORCID 0000-0001-9647-3416
Most cited papers
- Verified
P-71 KRYSTAL-10: A randomized phase 3 study of adagrasib (MRTX849) in combination with cetuximab vs chemotherapy in patients with previously treated advanced colorectal cancer with KRASG12C mutation
Tabernero, J., Bendell, J., Corcoran, R., Kopetz, S., Lee, J., Davis, M., Christensen, J., Chi, A., Kheoh, T., & Yaeger, R. (2021) · Annals of Oncology
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 28
- Verified
LBA1 Second-line adagrasib plus cetuximab vs chemotherapy in patients with KRASG12C-mutated metastatic colorectal cancer: Results from the KRYSTAL-10 trial
Tabernero, J., Kopetz, S., Lee, J., Corcoran, R. B., Hecht, J. R., Shen, L., Lonardi, S., Chen, Y., Fuang, H. G., Chen, Z., et al. (2026) · Annals of Oncology
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free